GYRE Operating Cash Flow Growth
Gyre Therapeutics Inc · Operating Cash Flow Growth
GYRE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-1753.02%period ending
GYRE TTM Cash from Operations YoY % (62.31% → -1753.02%)
Year-over-year change
High-resolution chart · PNG
GYRE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -1,753.0217% | |
| 163.3006% | |
| 126.5092% | |
| 67.9809% | |
| -89.3231% | |
| -137.1643% | |
| -114.715% | |
| -96.4399% | |
| -83.5625% | |
| -44.6084% | |
| -18.3798% | |
| 329.4749% | |
| 217.3732% | |
| 165.7574% | |
| 137.8754% | |
| 67.9663% | |
| 46.5152% | |
| 32.4477% | |
| -52.149% | |
| -114.9843% | |
| -114.4712% | |
| -123.0946% | |
| -26.2192% | |
| 7.8859% | |
| 12.5821% | |
| 12.9127% | |
| -52.744% | |
| -72.2224% | |
| -78.646% | |
| -85.0349% | |
| -43.1946% | |
| -39.0269% | |
| -26.5495% | |
| -15.1776% | |
| -7.9472% | |
| 0.1985% | |
| -6.342% | |
| 7.1852% | |
| 3.379% | |
| -9.4491% | |
| 14.1385% | |
| 19.3863% | |
| 44.5582% | |
| 60.0272% | |
| 53.9206% | |
| 47.8001% | |
| 15.0916% | |
| -3.7861% | |
| -6.9408% | |
| 5.181% | |
| 36.7798% | |
| 43.9023% | |
| 48.3716% | |
| 43.7943% | |
| 23.2674% | |
| 7.2697% | |
| -3.9005% | |
| -49.0171% | |
| -160.5345% | |
| -155.4542% | |
| -148.2579% | |
| -136.8008% | |
| 669.8076% | |
| 919.0349% | |
| 683.5866% | |
| 638.2056% | |
| 14.1184% | |
| 25.9879% | |
| -1,791.7441% | |
| -841.1699% | |
| -213.781% | |
| -214.3113% | |
| 393.8455% | |
| 170.5597% | |
| 351.0855% | |
| 284.3667% | |
| 95.9454% | |
| 108.897% | |
| 62.3101% |